Navigation Links
Scientists Unveil Mechanism Behind Resistance to Severe Malaria

Scientists have discovered why some people are less prone to malaria//. The people with a specific type of hemoglobin — the oxygen-carrying molecule that gives red blood cells their color — are less prone to severe malaria. In a series of experiments, the researchers determined how hemoglobin type C impairs the ability of malaria parasites to cause disease symptoms.

“This research gives us a new insight into malaria, a major global killer that preys especially on young children and claims a life every 30 seconds,” notes Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, where the research was conducted.

“If we better understand the natural protective mechanisms against malaria, we might be able to mimic that protective effect through vaccines or drugs,” says NIAID researcher Thomas E. Wellems, M.D., Ph.D., whose team’s findings appear this week in the journal Nature.

Nature has probably mutated the hemoglobin gene to protect the people from malaria in endemic regions. Hemoglobin exists in several varieties. Hemoglobin A is the most common, but in parts of West Africa, where malaria is rife, one-fourth of the population has at least one gene for hemoglobin C. Children with at least one hemoglobin C gene are less prone to deadly cerebral malaria, in which parasite-infected red blood cells accumulate in the brain. But the mystery is how does hemoglobin C confers this protection to the person. To solve the mystery, Dr. Wellems and his colleagues studied laboratory-infected red blood cells and blood drawn from children with malaria from the African nation of Mali and studied three phenenomenon and found how well parasitized red blood cells can be made to stick to one another, to uninfected red blood cells and to blood vessel walls. These phenomena — known respectively as agglutination, rosetting and cytoadherence — all depend on a parasite p rotein called PfEMP-1.

To evade the immune system, the malarial parasites produce proteins, including PfEMP-1, that remodel the red blood cell’s surface to their advantage. For example, when spikes of PfEMP-1 are distributed evenly over the surface of an infected AA red blood cell, they act like grappling hooks, allowing the parasitized cells to stick in tiny capillaries and avoid being cleared from the bloodstream. When parasite-infected red blood cells stick to blood vessel walls, the resulting inflammation may increase the severity of malarial symptoms, explains Dr. Wellems.

Dr. Wellems and his colleagues found uneven and reduced distribution of PfEMP-1 on the surface of parasite-infected red blood cells from children with at least one hemoglobin C gene. This abnormal distribution of PfEMP-1 significantly impairs the infected cells’ “stickiness.” For instance, laboratory-grown, parasitized AC blood cells agglutinated at a 75 percent lower rate than did AA red blood cells, while parasitized CC blood cells did not stick to each other at all. Rosette formation, in which parasitized cells attach to non-parasitized cells, also occurred significantly less often with AC and CC blood cells than with AA blood cells. Rosettes can impede blood flow in small vessels of the brain, contributing to cerebral malaria and death, notes Dr. Wellems. The scientists showed that AA cells often stick to blood vessel walls, whereas this occurs much less often with both AC and CC blood cells.

Together, the data from Dr. Wellems’ team may explain why red blood cells containing hemoglobin C are less hospitable to malaria parasites than normal AA red blood cells. For people with at least one gene for hemoglobin C, the result is less severe malaria.

Reference: RM Fairhurst et al. Abnormal PfEMP-1 display on hemoglobin C erythrocytes may protect against malaria. Nature 435:1117-21 (2005) doi:10.1038nature/03631. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.naid.nih.gov,
'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Warn Against Food Borne Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... Engineers at the University of Maryland have ... same kind of electrical energy that the body uses. , In ordinary batteries ... flow of electrons out of the battery is generated by moving positive ions from ...
(Date:7/24/2017)... TX (PRWEB) , ... July 24, 2017 , ... ... student scholarship will be awarded for the fall semester to a deserving student. ... Emergency Centers Spring 2017 scholarship was awarded to Mariana Castillo who is a nursing ...
(Date:7/24/2017)... ... July 24, 2017 , ... Horizon Goodwill Industries, SourceAmerica ... that helps high school girls succeed in STEM programs as well as help ... will host over 20 high school girls at their corporate headquarters on Tuesday, ...
(Date:7/24/2017)... ... July 24, 2017 , ... The International Essential Tremor Foundation (IETF) ... called essential tremor (ET). The seminar will take place on Saturday, Aug. 26 at ... OH. The program will run from 9 a.m. to 12 p.m., with check-in beginning ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... of media initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin ... is one of the leading causes of long term skin conditions, including cancer. ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017  BDI Group subsidiary ... patient support services organization serving specialty pharmacies, home ... launch of four significant, value-added member programs designed ... better manage reimbursement and improve access and affordability ... therapies. ...
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
Breaking Medicine Technology: